Clinical Trial Update: Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

Clinical trial update from UT Southwestern Medical Center describes evaluating the Ultromics EchoGo HFpEF algorithm to identify and treat patients at high risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Heart Failure, Diabetes | NA | Status: RECRUITING